Search results
Results from the WOW.Com Content Network
Psychological therapies for dementia are starting to gain some momentum. [ when? ] Improved clinical assessment in early stages of Alzheimer's disease and other forms of dementia , increased cognitive stimulation of the elderly, and the prescription of drugs to slow cognitive decline have resulted in increased detection in the early stages.
Medication therapy management, generally called medicine use review in the United Kingdom, is a service provided typically by pharmacists, medical affairs, and RWE scientists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. [1]
Direct Observation Form (DOF) – For ages 6 through 11. Adult assessments: Adult Self-Report (ASR) – To be completed by the adult. This assesses the adult's adaptive functioning, strengths, and problems. Adult Behavior Checklist (ABCL) – To be completed by a known individual of the adult, meant to reflect answers provided on the ASR.
Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications ...
Psychedelic therapy uses some type of hallucinogenic, often MDMA, ketamine, or psilocybin, alongside facilitated psychotherapy to open up a client’s mind and invite new perspectives to the table ...
[2] [3] They emphasize deprescribing medications that are unnecessary, which helps to reduce the problems of polypharmacy, drug interactions, and adverse drug reactions, thereby improving the risk–benefit ratio of medication regimens in at-risk people. [4] The criteria are used in geriatrics clinical care to monitor and improve the quality of ...
Donepezil, sold under the brand name Aricept among others, is a medication used to treat dementia of the Alzheimer's type. [3] [4] [8] It appears to result in a small benefit in mental function and ability to function. [9] Use, however, has not been shown to change the progression of the disease. [10] Treatment should be stopped if no benefit ...
Dementia and amnestic disorder became major or mild neurocognitive disorder (major NCD, or mild NCD). [11] [36] DSM-5 has a new list of neurocognitive domains. [11] "New separate criteria are now presented" for major or mild NCD due to various conditions. [11] Substance/medication-induced NCD and unspecified NCD are new diagnoses. [11]